VIRAL: Trump Asks for ‘Ibogaine,’ a Psychedelic Drug, During Press Briefing

A viral moment is gaining traction after President Donald Trump mentioned ibogaine — a powerful psychedelic drug — during an Executive Order signing today, sparking widespread reaction. Ibogaine is a psychoactive substance derived from a West African plant and is currently being researched for potential use in treating addiction and PTSD. However, it remains illegal in the United States and is classified as a Schedule I drug, meaning it is not approved for medical use. While some researchers and advocates point to its possible benefits in treating substance dependence, ibogaine is also associated with serious health risks, including heart complications and neurological effects. Due to these safety concerns, it has not received FDA approval and remains highly controversial in medical and policy circles. Trump’s unexpected reference to the drug has fueled conversations around experimental treatments, mental health, and the growing interest in psychedelic therapies — while also raising questions about safety, regulation, and public awareness. In this video we cover: • Trump’s ibogaine comment explained • What ibogaine is and why it’s trending • The legal status and health risks of the drug • The broader debate around psychedelic treatments Watch the full video for the complete moment and stay updated on viral political clips, trending news, and major debates shaping public conversation. #DonaldTrump #Ibogaine #Psychedelics #MentalHealth #USA #USPolitics #America #BreakingNews